IMPORTANCE Given the high prevalence of obstructive sleep apnea (OSA), there is a need for simpler and automated diagnostic approaches.
Introduction
Obstructive sleep apnea (OSA) affects almost 1 billion people worldwide, resulting in high socioeconomic and health care burden. 1 Excessive daytime sleepiness and fatigue, the chief problems reported by patients with OSA, may have negative consequences on neurocognitive function, mood, and productivity at work, leading to decreased quality of life and increased risk of occupational injuries and motor vehicle crashes. [2] [3] [4] [5] Obstructive sleep apnea is also a major risk factor for a variety of medical conditions, increasing the risk and severity of cardiometabolic diseases, including hypertension, arrhythmias, stroke, coronary heart disease, type 1 and type 2 diabetes, and metabolic dysfunction, [6] [7] [8] ultimately resulting in increased overall mortality. 9 Continuous positive airway pressure, the first-line therapy for OSA, is effective in alleviating symptoms, restoring neurocognitive function, and improving quality of life. 10, 11 Although OSA is one of the most prevalent chronic diseases associated with a wide range of disabilities, it remains an underdiagnosed health problem. 1, [12] [13] [14] Polysomnography (PSG), the reference method and criterion-standard diagnostic tool for OSA, is unsuitable for the widespread use required to address the sleep apnea epidemic. The performance of PSG is onerous because of the complexity of implementation and the time-consuming and laborious scoring of multichannel recordings, including electroencephalogram, electrocardiogram, and respiratory signals. 15, 16 The manual scoring of sleep stages, microarousals, and respiratory events in a specialized clinic is tedious, technically challenging, and not suitable to the growing population in need of OSA evaluation. 17, 18 There is consensus among experts on the need to develop advanced diagnostic approaches that incorporate novel technologies providing valid surrogates for sleep staging and respiratory pattern evaluation. 19, 20 Therefore, artificial intelligence-driven sensors that automatically score sleep and respiratory events might be a future direction for OSA diagnosis. [21] [22] [23] In this context, the objective of this study was to assess the diagnostic capabilities of a novel technology predicated on mandibular movement (MM) analysis (Sunrise) compared with PSG in a large population of consecutive patients with suspected OSA. The Sunrise system represents a technological advancement that combines MM recordings with an automated analysis that is supported by machine learning. Mandibular movement analysis has the advantage of being a reliable marker of sleep fragmentation and respiratory effort, providing information on the obstructive nature of respiratory events during sleep. [24] [25] [26] [27] We hypothesized that the Sunrise system-derived respiratory disturbance index (Sr-RDI) would compare favorably with the PSG-derived RDI (PSG-RDI).
Methods

Study Design
In this prospective, diagnostic study of adult patients who were referred for a single overnight in-laboratory PSG, the PSG was used as the reference method and, with blinding, was compared with simultaneous MM recordings using the Sunrise system (a full description is given in the MM Hospitalo-Facultaire-Universitaire de Liège approved the study, and each participant provided written informed consent. This study followed the Standards for Reporting of Diagnostic Accuracy (STARD) reporting guideline.
Overnight Sleep Study
In-laboratory PSG was recorded with a digital acquisition system (Somnoscreen Plus; Somnomedics).
The parameters monitored included electroencephalogram (Fz−A+, Cz−A+, and Pz−A+), right and left electro-oculogram, submental electromyogram, tibial electromyogram, chest and abdominal wall motion by respiratory inductance plethysmography (SleepSense; S.L.P. Inc), and nasal and oral flows with a pressure transducer and a thermistor, respectively, as well as oxygen saturation by digital oximeter displaying pulse waveform (Nonin; Nonin Medical).
The PSG data were manually scored by 2 experienced investigators (V.C. and a nonauthor) who were blinded to the identity of the patients. All sleep stages, electroencephalogram arousals, and sleep-related respiratory events were visually scored in accordance with the recommended criteria established by the American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events. 28 Hypopneas were scored using the AASM-recommended hypopnea 1A definition, requiring at least a 30% decrement in airflow lasting 10 seconds or longer and associated with a decrease of at least 3% in oxygen saturation as measured by pulse oximetry or an arousal. 28, 29 Obstructive sleep apnea diagnosis was established according to the third edition of the International Classification of Sleep Disorders 30 (ICSD-3) and required either evoking signs or symptoms or related medical or psychiatric comorbidities coupled with at least 5 predominantly obstructive respiratory events (ie, obstructive and mixed apneas, hypopneas, or respiratory effort-related arousals [hereafter referred to as PSG-RDI]) per hour of sleep during PSG. Alternatively, a frequency of obstructive respiratory events of at least 15 events/h satisfied the diagnosis criteria even in the absence of associated symptoms or comorbidities. 31 Interobserver agreement for scoring PSG was evaluated for all studies by intraclass correlation coefficient (ICC) using a 2-way random model for single measures (ICC, 2.1). Interobserver agreement (ICC, 2.1) for PSG double-scoring was 92% (95% CI, 89%-94%; P < .001) in our laboratory. A prespecified, clinically relevant RDI difference of 3 events/h (with an upper bound at 5 events/h) between PSG-RDI and Sr-RDI was agreed on a priori by the study investigators (J-L.P., J-B.M., and D.G.).
MM Recordings and Description of the Sunrise System
The Sunrise system is composed of coin-sized hardware attached by the sleep technician to the chin of the patient in the mentolabial sulcus. Its embedded inertial measurement unit enables MM sensing and communicates with a smartphone application for external control. The collected MM data were automatically transferred to a cloud-based infrastructure at the end of the night, and data analysis was conducted with a dedicated machine learning algorithm (Figure 1) . Details on the algorithm and the independent sample in which it was developed are provided in eFigure 2, eTable 1, and eTable 2 in the Supplement.
The Sunrise algorithm allowed for automatic identification of obstructive and mixed apneas and hypopneas or respiratory effort-related arousals through stereotypical MM patterns (eFigure 1 in the Supplement). For that purpose, the algorithm automatically processed MM signal components and assessed whether MM patterns could be classified as wake, arousal, respiratory effort, or quiet sleep.
To identify wake, the algorithm tested whether MM signals were fast, irregular, and nonpredictable. 25, 26 For the identification of arousal movements, the algorithm detected brisk MM of large amplitude, indicating abrupt closure of the mouth characteristic of arousals. 27 Respiratory effort was identified through oscillating MM at the breathing frequency. 24 The Sunrise algorithm identifies respiratory disturbances as a period of respiratory effort ended by an arousal or an awakening. The Sr-RDI consists of the total number of respiratory disturbances accompanied by respiratory effort divided by the total sleep time (TST), which is estimated from the Sunrise analytics. 
JAMA Network Open | Pulmonary Medicine
Statistical Analysis
Data analysis was conducted using R statistical programming language (R Project for Statistical Computing). 32 The analysis focused on evaluating the agreement between MM-derived parameters (Sr-RDI, Sr-TST, and arousal index [Sr-ArI]) and their PSG counterparts (PSG-RDI, PSG-TST, and PSG-ArI) as well as optimizing the clinical performance of the RDI derived from Sunrise system analysis in ruling in a diagnosis of OSA at the 2 reference thresholds of PSG of at least 5 events/h or at least 15 events/h, leading to the classification of participants in the following 3 clinical groups:
non-OSA (OSA ruled out), PSG-RDI of at least 5 events/h (OSA ruled in with PSG-RDI Ն5 events/h and the patient had either signs or symptoms or a comorbid medical or psychiatric disorder), and PSG-RDI of at least 15 events/h (OSA is ruled in with PSG-RDI Ն15 events/h even in the absence of associated symptoms or comorbid disorders).
A complete and groupwise Bland-Altman plot 33 was prespecified to estimate the 95% limits of agreement and the systematic bias of MM-derived indexes compared with their PSG counterparts.
Estimations of the mean differences and 95% limits of agreement were based on the individual random errors extracted from a mixed model. 34 
Results
In total, 376 consecutive adults with suspected OSA were enrolled from July 5, 2017, to October 31, The characteristics of the cohort are listed in 
Evaluation of the Agreement Between the Sunrise System and PSG for Measuring Sleep Apnea Indexes
An extended Bland-Altman plot (Figure 2 ) was used to evaluate the agreement level between the Sunrise system-based approach and PSG (reference method) for RDI measurement and to anticipate the reliability of switching from PSG to the Sunrise system as a diagnostic tool. Overall, the Bland-Altman plot ( Figure 2B ) showed systematic bias between the 2 methods, with a mean difference of −7.00 events/h (95% CI, −15.24 to 1.23 events/h).
Detailed analysis ( Figure 2B) showed that in the non-OSA group (n = 46) the disagreement was normally distributed and below a clinically relevant difference (mean difference, 1.31; 95% CI, −1.05 to 3.66 events/h, thus including 0). The disagreement was also normally distributed in the OSA group with a PSG-RDI of at least 5 events/h (n = 107), and the mean difference was low (−0.69; 95% CI, The agreement between PSG-derived and Sunrise system-derived indexes for TST and ArI is shown in Bland-Altman plots in eFigure 3 and eFigure 4 in the Supplement. The difference in TST between the 2 methods contributed to less than 1 unit of the difference between RDIs.
Optimization of Sr-RDI Diagnostic Performance in OSA by ROC Curve Analysis
The variability of Sr-RDI among the 3 clinical groups was explored using pairwise comparisons in a
Gardner-Altman plot. The mean differences in Sr-RDI between patients with and without OSA diagnosed at the cutoffs of 5 events/h and 15 events/h were 6.11 (95% CI, 4.59-7.61; P < .001) and
21.20 (95% CI, 18.87-23.52; P < .001), respectively (eFigure 5 in the Supplement).
An ROC curve analysis was performed to evaluate the clinical performance of Sr-RDI diagnostic rules to detect PSG-defined OSA at the 2 clinical thresholds of 5 events/h and 15 events/h (Figure 3) . 
Discussion
In a large, prospective cohort of patients with and without OSA, we evaluated the agreement between MM-derived Sr-RDI and blindly scored PSG-RDI ( Figure 2B ). The maximum agreement between PSG-RDI and Sr-RDI was found in patients without OSA and in those with OSA with PSG-RDI of at least 5 events/h, with the latter group representing the most challenging population to be diagnosed when using simplified approaches. 35
Diagnostic Capabilities of the Sunrise System vs PSG
The study sample was representative of a typical clinical referral population, including patients with low to high pretest probability of OSA, thus embracing the entire spectrum of OSA. This factor is clinically relevant because simple and less onerous diagnostic strategies are particularly desirable in asymptomatic or specific at-risk populations, such as those with cardiometabolic disease or obesity. 36 Similar skewed RDI distributions were found for PSG and the Sunrise system irrespective of the group of patients being considered (Figure 2A) . Accordingly, the optimal diagnostic cutoff was adjusted, and the diagnostic PSG-RDI cutoffs of at least 5 events/h and at least 15 events/h could be extrapolated with confidence to Sr-RDI cutoffs of at least 7.63 events/h and at least 12.65 events/h. with other OSA diagnostic systems, as well as reducing medical errors by facilitating the complex process of respiratory event scoring.
Limitations
This study has limitations. First, the chosen Sr-RDI cutoff of 7.63 leaves 9% of individuals as having false-negative results. However, a lower cutoff would optimize sensitivity at the expense of a large decrease in specificity. This factor may be addressed by increasing the number of recording nights.
Similar to the Sunrise system device, the criterion-standard reference method using 1-night PSG might underestimate positive diagnosis in mild to moderate OSA. However, discomfort caused by electrodes and cables combined with an unfamiliar environment may result in a first-night effect.
Repeated PSG has been suggested in sensitive populations (eg, those with insomnia and sleep apnea). 49 The use of the Sunrise system has greater capability than PSG for repeating nights at lower cost.
Second, it is theoretically possible that measurement of the amplitude of mandibular displacement was limited by localized constraints (ie, friction with the pillow in the lateral or prone position of the head or by excessive adipose tissue around the neck), slightly altering results of the automated Sunrise system analysis. Future studies will address these issues in more depth.
Third, the data were obtained in a sleep laboratory and will thus require confirmation and validation via home-based recordings in an ambulatory setting. A future study will evaluate the diagnostic capabilities of the Sunrise system in home-based settings by comparing ambulatory PSG results with consecutive nocturnal recordings using the Sunrise system, with the aim of reducing the consequences of internight variability.
Fourth, relative to the anticipated lower cost associated with the use of the Sunrise system, medicoeconomic data are needed to document inequalities in access to sleep apnea diagnosis and treatment. This information will address possible increases in disease detection and intervention, with potential attendant benefits on outcomes.
Conclusions
The Sunrise system automated analysis of MM provided an accurate estimation of RDI obtained during traditional PSG in a large cohort of patients with and without OSA. This approach may provide a suitable and convenient home-based alternative to the sleep center setting and serve as a standalone tool for automated assessment of OSA.
